Back to CVE records
High 7.5HealthcarePublished Apr 1, 2022

CVE-2021-27501Philips Vue PACS Improper Adherence to Coding Standards

Updated under an hour ago ()

Does this affect you?

It affects Philips Vue PACS and 5 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.92%, higher than 60% of scored CVEs.

Philips Vue PACS versions 12.2.x.x and prior does not follow certain coding rules for development, which can lead to resultant weaknesses or increase the severity of the associated vulnerabilities.

CVSS
7.5 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-710
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.92% (percentile 60)
Assigned by
icscert
NVD analysis
Modified
Record last updated
Apr 16, 2025
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
Philips Vue PACS
philips:vue_pacs (from the name)
from unspecified through 12.2.x.x
CNA record
Philips Vue MyVue
philips:vue_myvue (from the name)
from unspecified through 12.2.x.x
CNA record
Philips Vue Speech
philips:vue_speech (from the name)
from unspecified through 12.2.x.x
CNA record
Philips Vue Motion
philips:vue_motion (from the name)
from unspecified through 12.2.1.5
CNA record
philips myvue
philips:myvue
before 12.2.1.5
NVD
philips speech
philips:speech
before 12.2.8.0
NVD
philips vue_motion
philips:vue_motion
before 12.2.1.5
NVD
philips vue_pacs
philips:vue_pacs
before 12.2.8.0
NVD

References

  • x-refsource-confirm, mitigation, third-party-advisory, us-government-resource
  • x-refsource-confirm, vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.